JPH0330648A - Readily absorbable mineral-containing food and drink - Google Patents

Readily absorbable mineral-containing food and drink

Info

Publication number
JPH0330648A
JPH0330648A JP1166404A JP16640489A JPH0330648A JP H0330648 A JPH0330648 A JP H0330648A JP 1166404 A JP1166404 A JP 1166404A JP 16640489 A JP16640489 A JP 16640489A JP H0330648 A JPH0330648 A JP H0330648A
Authority
JP
Japan
Prior art keywords
calcium
mineral
drink
natto
minerals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1166404A
Other languages
Japanese (ja)
Other versions
JP2712583B2 (en
Inventor
Tadashi Noguchi
野口 忠
Hiroyuki Tanimoto
浩之 谷本
Masao Motoki
本木 正雄
Masahito Mori
将人 森
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ajinomoto Co Inc
Original Assignee
Ajinomoto Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ajinomoto Co Inc filed Critical Ajinomoto Co Inc
Priority to JP1166404A priority Critical patent/JP2712583B2/en
Publication of JPH0330648A publication Critical patent/JPH0330648A/en
Application granted granted Critical
Publication of JP2712583B2 publication Critical patent/JP2712583B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

PURPOSE:To obtain the subject food and drink, containing a mineral and poly-alpha- or poly-gamma-glutamic acid as a mineral absorption promoter, capable of increasing the soluble mineral concentration in intestinal tracts and useful for preventing osteopathy, etc. CONSTITUTION:The objective food and drink containing a mineral (preferably Ca, Fe, Mg, Zn or Cu) and poly-alpha- or poly-gamma-glutamic acid as a mineral absorption promoter.

Description

【発明の詳細な説明】 〔産業上の利用分野〕 本発明はミネラル吸収促進効果を有する飲食物に関する
。詳しくは、ミネラル及びミネラル吸収促進材としてポ
リ−α又はT−グルタミン酸を含有する飲食物に関し、
さらにはミネラル及びミネラル吸収促進材として納豆あ
るいは納豆菌由来の粘質物を含有する飲食物に関する。
DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a food or drink that has the effect of promoting mineral absorption. Specifically, regarding minerals and foods and drinks containing poly-α or T-glutamic acid as a mineral absorption promoter,
Furthermore, the present invention relates to foods and drinks containing natto or mucilage derived from Bacillus natto as minerals and mineral absorption promoters.

〔従来の技術〕[Conventional technology]

生体を構成するミネラルには約20種類あるが、このう
ちカルシウム、鉄、亜鉛、銅、マグネシウムなどは日本
人にとって不足しがちで栄養学上問題視されている。特
にカネシウム、鉄は不足しがちである。
There are about 20 types of minerals that make up the living body, but among these, Japanese people tend to be deficient in minerals such as calcium, iron, zinc, copper, and magnesium, which is considered a nutritional problem. In particular, we tend to be deficient in magnesium and iron.

カルシウムの場合、成人1日の所要量は600■とされ
ており、国民1人あたりの摂取量はやや下回っている程
度であるが、その吸収率の低さが原因となってカルシウ
ム不足が問題となっている。
In the case of calcium, the daily requirement for an adult is said to be 600 kg, which is slightly below the intake per person, but calcium deficiency is a problem due to its low absorption rate. It becomes.

高齢者に高頻度に発症する骨粗N症はカルシウムの摂取
と排泄のバランスが乱れることが主たる要因であり、ね
たきり老人を増加させる主たる原因である。骨粗鬆症は
特に閉経後の女性に多く発症するが、女性ホルモン(ニ
ストロジエン)の分泌が著しく低下し小腸からのカルシ
ウムの吸収率が低下することも原因の一つと考えられて
いる。骨粗N症患者は年々増加しており、2000年に
は534万人になろうという。
Osteoporosis N, which frequently occurs in the elderly, is mainly caused by an imbalance between calcium intake and excretion, and is the main cause of the increase in the number of bedridden elderly people. Osteoporosis occurs particularly often in postmenopausal women, and one of the causes is thought to be a marked decline in the secretion of female hormones (nistrodiene) and a decline in the absorption rate of calcium from the small intestine. The number of osteoporosis patients is increasing year by year, and it is estimated that there will be 5.34 million people by 2000.

一般にミネラルが吸収されるには可溶性の状態で小腸管
腔内に存在することが必要であるとされている。カルシ
ウムの場合、小腸上部でのビタミンDや各種ホルモンの
調節により制御されている、カルシウムが濃度勾配にさ
からって吸収される能動輸送の経路と小腸下部でのカル
シウムが濃度勾配に従って吸収される受動輸送の経路の
2通りがある。ところが圧倒的に小腸下部からの受動輸
送の割合が高く、能動輸送がカルシウム濃度が増加して
もある量販上は増加しないのに比べ、受動輸送は腸管内
の可溶性カルシウム濃度が増加すれば、それだけ輸送能
も高まる。
It is generally believed that in order for minerals to be absorbed, they must be present in the lumen of the small intestine in a soluble state. In the case of calcium, there is an active transport pathway in which calcium is absorbed against the concentration gradient, which is controlled by the regulation of vitamin D and various hormones in the upper small intestine, and an active transport pathway in which calcium is absorbed in the lower small intestine according to the concentration gradient. There are two routes of passive transport. However, the proportion of passive transport from the lower part of the small intestine is overwhelmingly high, and while active transport does not increase in terms of mass sales even if the calcium concentration increases, passive transport increases as much as the soluble calcium concentration in the intestinal tract increases. Transport capacity will also increase.

小腸下部での可溶性カルシウム濃度および可溶性鉄濃度
を増加させることによりカルシウムおよび鉄の吸収促進
効果を示す素材に牛乳蛋白質のカゼインの分解物である
カゼインホスホペプチドがある。カゼインホスホペプチ
ドは含有するホスホセリンのリン酸基、酸性アミノ酸の
カルボキシル基によるキレート作用により、カルシウム
、鉄が可溶化状態に保たれ、小腸内の可溶性カルシウム
濃度、可溶性鉄濃度を増加させることにより吸収促進作
用をもつといわれているが、カゼインホスホペプチドを
生成するには酵素処理等の複雑な工程を経る必要があり
、しかも食品に添加した場合に、小腸に転送される過程
でさらに分解が進む可能性がある。カゼインをそのまま
食した場合にも、腸管内で分解されカゼインホスホペプ
チドが生成するため、ミネラルの吸収が促進される。し
かし、この場合にも腸管内で分解が進行し、ミネラル可
溶化能が消失する場合があり、またカゼインは溶解性が
悪いなどの欠点もある。
Casein phosphopeptide, which is a decomposition product of the milk protein casein, is a material that exhibits the effect of promoting calcium and iron absorption by increasing the soluble calcium concentration and soluble iron concentration in the lower small intestine. Casein phosphopeptide maintains calcium and iron in a solubilized state due to the chelating action of the phosphate group of phosphoserine and the carboxyl group of acidic amino acids contained in it, and promotes absorption by increasing the concentration of soluble calcium and soluble iron in the small intestine. However, producing casein phosphopeptides requires complex processes such as enzymatic treatment, and furthermore, when added to food, it may be further degraded during the process of being transferred to the small intestine. There is sex. Even when casein is eaten as is, it is broken down in the intestinal tract to produce casein phosphopeptides, which promotes mineral absorption. However, in this case as well, decomposition progresses in the intestinal tract and the ability to solubilize minerals may be lost, and casein also has drawbacks such as poor solubility.

また、無機のミネラル塩とかミネラル粉末を食品に添加
する場合もあるが、他の共存する物質と不溶性の塩を作
る可能性が太き(ミネラルの生体内利用性はあまり改善
されない。ポリグルタミン酸(分子量14.000)が
in vitroの系においてカルシウムを可溶化する
ことはすでに知られていた(日本栄養食糧学会誌j1!
1(6) 433−439 (1986))が、ポリグ
ルタミン酸のin vitroO系におけるミネラル可
溶化がin vitroと同じ挙動を示すか否かは開示
されておらず又まったく予測すらできていなかった。
Also, in some cases, inorganic mineral salts or mineral powders are added to foods, but there is a high possibility that they will form insoluble salts with other coexisting substances (the bioavailability of minerals will not be improved much. Polyglutamic acid ( It was already known that calcium (molecular weight 14.000) solubilizes calcium in an in vitro system (Japanese Journal of Nutrition and Food Science J1!
1(6) 433-439 (1986)) did not disclose whether or not mineral solubilization of polyglutamic acid in an in vitro O system exhibits the same behavior as in vitro, nor could it be predicted at all.

〔発明が解決しようとする課題〕[Problem to be solved by the invention]

処理工程が簡便であり、溶解性良好で安全ではば広(食
品に利用でき得る成分を開発し、これを用いてミネラル
吸収促進効果をもつ飲食物を開発することである。
The goal is to develop ingredients that have simple processing steps, good solubility, and are safe and widely usable in foods, and use these to develop foods and drinks that have the effect of promoting mineral absorption.

〔課題を解決する為の手段〕[Means to solve problems]

発明者らはミネラルを腸管内で可溶化状態に保つにはポ
リグルタミン酸が最も適しており、これを用いることに
より腸管を通してミネラルが体内吸収しやすくなること
を見出した結果、更に開発研究を行ないミネラルを体内
に補給し易い形の飲食物の開発に成功し、本発明を完成
させたものである。
The inventors found that polyglutamic acid is the most suitable for keeping minerals in a solubilized state in the intestinal tract, and that by using polyglutamic acid, minerals can be easily absorbed into the body through the intestinal tract.As a result, they conducted further research and development to improve mineral The present invention has been completed by successfully developing a food and drink that can be easily replenished into the body.

すなわち本発明はミネラル及びミネラル吸収促進材とし
てポリ−α又はγ−グルタミン酸とを含有することを特
徴とする飲食物である。
That is, the present invention is a food or drink characterized by containing a mineral and poly-α or γ-glutamic acid as a mineral absorption promoter.

本発明で用いるミネラルとしてカルシウム、鉄、マグネ
シウム、亜鉛、銅などの生体必須ミネラルの一部あるい
は全部が対象となる0本発明に用いるポリグルタミン酸
はα結合でもγ結合でもよく、また、純度が高いもので
もよいが、必ずしも純度が高い必要はなく、ポリグルタ
ミン酸を一構成成分とする納豆粘質物も利用できる。納
豆粘質物はポリーγ−グルタミン酸とレバンからなるが
、他の蛋白質、ペプチド、糖を含有していても本発明の
実施には何ら影響しない。
The minerals used in the present invention include some or all of the essential minerals for living organisms such as calcium, iron, magnesium, zinc, and copper.The polyglutamic acid used in the present invention may be α-linked or γ-linked, and has high purity. However, it does not necessarily have to be highly pure, and natto mucilage containing polyglutamic acid as one of its constituents can also be used. Although the natto mucilage consists of poly-γ-glutamic acid and levan, it does not affect the practice of the present invention even if it contains other proteins, peptides, and sugars.

納豆粘質物の粘性を利用した食品加工物の例は今までに
あるが、納豆粘質物を用いることによりミネラル吸収促
進効果を有する飲食物を開発したものである。
Although there have been examples of processed food products that utilize the viscosity of natto mucilage, we have developed a food and drink product that uses natto mucilage to promote mineral absorption.

飲食物としては、乳酸飲料、ジュース、清涼飲料などの
飲料形態、ゼリーなどのゲル状形態、菓子、ビスケット
、錠菓などの固型状形態、さらにふりかけなどの粉粒状
形態などのどの形態にも使用できる。・納豆粘質物の場
合、その調製段階で有臭成分が減縮ないしは完全に除か
れるので、臭いなどの使用上の制限要因はなく、どの割
合でも添加することができる。ポリグルタミン酸の場合
も添加割合の制限要因はない、しかし、一般に乾燥食品
には0.1〜10%程度、飲料の場合は0.01〜5%
程度、製品に添加すればよい。尚、同時にカルシウム、
鉄などのミネラルをあわせ添加するが、これらの添加量
は通常用いられる量でよい。
Foods and drinks can be in any form, including beverages such as lactic acid drinks, juices, and soft drinks, gels such as jelly, solids such as sweets, biscuits, and tablets, and even powders such as furikake. Can be used. - In the case of natto mucilage, the odorous components are reduced or completely removed during the preparation stage, so there is no restriction on use such as odor, and it can be added in any proportion. In the case of polyglutamic acid, there is no limiting factor for the addition ratio, but it is generally around 0.1-10% for dry foods and 0.01-5% for drinks.
It can be added to the product to a certain degree. At the same time, calcium
Minerals such as iron are also added, but the amount of these additions may be the amount normally used.

本発明で用いるポリグルタミン酸はα−ポリグルタミン
酸でもγ−ポリグルタミン酸でもよく、納豆菌の分泌す
る粘質物あるいは納豆の粘質物よりそれらを単離して用
いてもよく、また粘質物をそのまま用いても何ら支障は
ない。
The polyglutamic acid used in the present invention may be α-polyglutamic acid or γ-polyglutamic acid, and it may be used after being isolated from the mucilage secreted by Bacillus natto or the mucilage of natto, or the mucilage may be used as it is. There are no problems.

実施例 く納豆粘質物の調製例〉 市販の納豆1kgを3倍世の水で洗浄した後、が布によ
り豆の部分を除去した。粘稠な炉液を遠心分離し、その
上清をエタノールに最終濃度が85%エタノールとなる
よう徐々に滴加し、沈殿する精魂を集め、蒸留水に溶解
した。さらにエタノールに滴加する操作を繰り返した後
、沈殿した精魂を蒸留水に溶解し、凍結乾燥して乾燥粉
末13gを得た。この納豆粘質物の蛋白含量は54%、
糖含量は44%、蛋白質のうち70%がグルタミン酸で
あった。
Example Preparation of Natto Mucilage Product> After washing 1 kg of commercially available natto with 3 times the amount of water, the bean part was removed with a cloth. The viscous furnace solution was centrifuged, and the supernatant was gradually added dropwise to ethanol to give a final concentration of 85% ethanol, and the precipitated spirits were collected and dissolved in distilled water. After repeating the operation of adding dropwise to ethanol, the precipitated spirit was dissolved in distilled water and freeze-dried to obtain 13 g of dry powder. The protein content of this natto mucilage is 54%.
The sugar content was 44%, and 70% of the protein was glutamic acid.

実施例1 〈カルシウム可溶化試験〉 この納豆粘質物を用いて以下の実験をおこなった。Example 1 <Calcium solubilization test> The following experiment was conducted using this natto mucilage.

納豆粘質物溶液(1mg/+nj2)の0.5n+42
と10mM塩化カルシウム溶液0.5n/!を予め混合
し、その後pH7、pH8の20mMリン酸緩衝液1、
0 m lを加え、37°Cで2時間インキュベーショ
ンした後遠心分離した。生じたリン酸カルシウムの沈殿
を除去し、上清のカルシウム濃度を原子吸光法により測
定し、残存しているカルシウムを可溶性カルシウムとし
て残存率を求めた。比較対照として納豆粘質物溶液の代
りに蒸留水を用い同一試験をおこなった。その結果を表
1に示す。
0.5n+42 of natto mucilage solution (1mg/+nj2)
and 10mM calcium chloride solution 0.5n/! pre-mix and then add 20mM phosphate buffer 1, pH 7, pH 8,
0 ml was added, incubated at 37°C for 2 hours, and then centrifuged. The resulting calcium phosphate precipitate was removed, and the calcium concentration of the supernatant was measured by atomic absorption spectrometry, and the remaining calcium was determined as soluble calcium to determine the residual rate. As a comparison, the same test was conducted using distilled water instead of the natto mucilage solution. The results are shown in Table 1.

実施例2 く動物試験例〉 ラット(Sprague−Dawley系雄性4週令各
群n=8)を10日間明朗の8時間(9:00〜17:
00)ミールフィーディングした後、所要量のカルシウ
ムを含む試験食を1.5時間項食させ、更に1時間後に
ジエチルエーテル麻酔下にて開腹し、小腸上部(前半部
)および下部(後半部)の内容物を生理的食塩水(0,
9%Nal、l)に懸濁採取した。
Example 2 Animal test example> Rats (Sprague-Dawley male, 4 weeks old, n = 8 in each group) were subjected to 8 hours of light light (9:00-17:00) for 10 days.
00) After meal feeding, a test meal containing the required amount of calcium was fed for 1.5 hours, and after another 1 hour, the abdomen was opened under anesthesia with diethyl ether and the upper (first half) and lower (second half) small intestine were examined. The contents of the saline solution (0,
The suspension was collected in 9% Nal, 1).

生理的食塩水は定容後、遠心分離し、可溶性および不溶
性画分に分け、それぞれのカルシウム量を原子吸光法に
より測定した。ラットには試験食として20%納豆粘質
物食、20%分離大豆蛋白質食、20%納豆凍結乾燥物
食、20%粘質物除去納豆凍結乾燥物食、20%カゼイ
ン食を与えた。
After the physiological saline solution had been fixed in volume, it was centrifuged and separated into soluble and insoluble fractions, and the amount of calcium in each fraction was measured by atomic absorption spectrometry. The rats were given 20% natto mucilage diet, 20% isolated soybean protein diet, 20% natto freeze-dried diet, 20% mucilage-free natto freeze-dried diet, and 20% casein diet as test foods.

結果は表2に可溶性カルシウムと不溶性カルシウムの割
合を示した。
The results are shown in Table 2, which shows the ratio of soluble calcium to insoluble calcium.

以上の結果より納豆粘質物には小腸内の可溶性カルシウ
ムを増大させる作用があり、それによりカルシウムの吸
収を促進する作用があることが明らかになった。またそ
の可溶化の程度はカゼインと同等であり、カゼインの酵
素分解物であるカゼインホスホペプチドと同等の効果を
持つことが明らかになった。
The above results revealed that natto mucilage has the effect of increasing soluble calcium in the small intestine, thereby promoting calcium absorption. It was also revealed that the degree of solubilization is the same as that of casein, and that it has the same effect as casein phosphopeptide, which is an enzymatic decomposition product of casein.

カルシウム以外のミネラルについても納豆粘質物はやは
り同様の小腸内可溶化促進作用をもち、小腸におけるそ
の吸収を促進する。
Regarding minerals other than calcium, natto mucilage also has a similar effect of promoting solubilization in the small intestine, and promotes their absorption in the small intestine.

実施例3 〈飲食品への適用例〉 次に実施例2で調製した納豆粘質物および納豆菌を培養
して得たポリグルタミン酸を添加した飲食物について示
す。
Example 3 <Example of application to food and drink> Next, food and drink to which the natto mucilage prepared in Example 2 and polyglutamic acid obtained by culturing Bacillus natto are added will be described.

3−1 パイナツプルジュース パイナツプル濃縮果汁8.3g、果糖ぶどう糖液1!!
18.5g、庶’fJfI 液F! 4.6 g、クエ
ン酸0.24g、ビタミンC0,04g、ポリグルタミ
ン酸1.0g。
3-1 Pineapple juice pineapple concentrated fruit juice 8.3g, fructose glucose solution 1! !
18.5g, 庶'fJfI Liquid F! 4.6 g, citric acid 0.24 g, vitamin C 0.04 g, polyglutamic acid 1.0 g.

炭酸カルシウム3.8gに水を8.3g加え混合し、香
料を0.22 g添加してシラツブを作った。このシラ
ツブに4倍量の水を添加し、ストレーニングしおりを除
いた後加熱殺菌して冷却しパイナツプルジュースを調製
した。
8.3 g of water was added to 3.8 g of calcium carbonate and mixed, and 0.22 g of flavoring agent was added to make a syrup. Four times the amount of water was added to this syllabary, and after removing the straining bookmarks, it was heat sterilized and cooled to prepare pineapple juice.

3−2 クツキー 小麦粉200g、砂糖120g、バター100g、全卵
40g1ポリグルタミン酸15g、炭酸カルシウム20
g1ベイキングパウダー3g1バニラエツセンス1g、
食塩1gを用いて生地を生成し、冷却した後、整型して
焙焼しクツキーを調製した。
3-2 200g of Kutsky flour, 120g of sugar, 100g of butter, 40g of whole eggs, 15g of polyglutamic acid, 20g of calcium carbonate
g1 baking powder 3g1 vanilla essence 1g,
A dough was prepared using 1 g of common salt, cooled, shaped and roasted to prepare kutsky.

3−3 羊かん 寒天2.6gを浸漬し充分吸水した後、水洗脱水し、細
かくちぎって鍋に入れ水72ml加えて加熱混合し、寒
天を完全に溶解させた。さらに砂糖180g、ポリグル
タミン酸6g、炭酸カルシウム10gを加えて加熱し沸
騰させ、篩でこした後が液を再び沸騰させ、生あんを1
10g加えて練り上げた。温かいうちに缶などの型枠に
流しこんで放冷し、凝固させ羊かんを調製した。
3-3 After soaking 2.6 g of Yokan agar and absorbing enough water, it was washed with water, dehydrated, broken into small pieces, placed in a pot, added with 72 ml of water, and mixed with heat to completely dissolve the agar. Furthermore, add 180 g of sugar, 6 g of polyglutamic acid, and 10 g of calcium carbonate, heat to boil, strain through a sieve, bring the liquid to a boil again, and add 1
10g was added and kneaded. Yokan was prepared by pouring the mixture into molds such as cans while still warm and allowing it to cool and solidify.

3−4 レモンジュース レモン濃縮果汁2.1g、果糖ぶどう糖液糖10、 O
gとクエン酸0.16g、ビタミンC0,04g、ポリ
グルタミン酸2.0g、クエン酸鉄0.6gを水で溶解
したものと、ナリンジン0.03 gを加熱した水に溶
解したものとを混合し、香料を0.2g加えた。全量は
200gとなるようにした。その後ストレーニングし、
更に加熱殺菌し、レモンジュースを調製した。
3-4 Lemon juice Lemon concentrated juice 2.1g, fructose glucose liquid sugar 10, O
g, 0.16 g of citric acid, 0.04 g of vitamin C, 2.0 g of polyglutamic acid, 0.6 g of iron citrate dissolved in water, and 0.03 g of naringin dissolved in heated water were mixed. , 0.2 g of fragrance was added. The total amount was set to 200g. Then strain,
Furthermore, it was heat sterilized to prepare lemon juice.

3−5 ピーチネクター ビーチピユーレ120.0g、果糖ぶどう糖液糖26.
6g、グラニュー糖19.4g、クエン酸0.24g1
リンゴ酸0.32g、ビタミンC0,12g、納豆粘質
物2.0g、乳酸カルシウム15.4 gと水216、
0 gを混合し、デアレータ−で脱気した後、ホモゲナ
イズし、加熱殺菌した。その後冷却してピーチネクター
を調製した。
3-5 Peach nectar beach puree 120.0g, high fructose glucose liquid sugar 26.
6g, granulated sugar 19.4g, citric acid 0.24g1
0.32 g of malic acid, 0.12 g of vitamin C, 2.0 g of natto mucilage, 15.4 g of calcium lactate, and 216 g of water.
0 g were mixed, degassed using a dealerator, homogenized, and heat sterilized. Thereafter, it was cooled to prepare peach nectar.

3−6 キャラメル 砂P’220g、水あめ485gを少量の水に煮とかし
、冷却した後、牛乳80n+jl!、練乳130m2、
小麦粉40g、納豆粘質物15g、乳酸カルシウム50
gを徐々に加え、50°C〜60°Cに加熱しながら混
合した。混合後さらに煮つめた後、バター40gと香料
1gを混合し、容器に流しこみ放冷した。その後適当な
大きさに切り、キャラメルを調製した。
3-6 Boil 220g of caramel sand P' and 485g of starch syrup in a small amount of water, cool it, and add 80n+jl of milk! , condensed milk 130m2,
40g of wheat flour, 15g of natto mucilage, 50g of calcium lactate
g was gradually added and mixed while heating to 50°C to 60°C. After mixing and further boiling, 40 g of butter and 1 g of fragrance were mixed, poured into a container, and left to cool. Thereafter, it was cut into appropriate sizes and caramel was prepared.

〔発明の効果〕〔Effect of the invention〕

本発明はミネラル及びミネラル吸収促進材を含有するこ
とを特徴とする飲食物に関し、これを食することにより
腸管内に可溶性のミネラルの濃度が増加することによっ
てミネラルの吸収が促進され、成長期の児童のミネラル
の補強、老年期の骨粗■症に代表される骨疾患の予防、
さらに健康人においても高タンパク食などによっておこ
るミネラルのアンバランスの防止などの効果が期待でき
る。
The present invention relates to foods and drinks that are characterized by containing minerals and mineral absorption promoters.Eating these foods increases the concentration of soluble minerals in the intestinal tract, thereby promoting mineral absorption. Mineral reinforcement for children, prevention of bone diseases such as osteoporosis in old age,
Furthermore, even in healthy people, it can be expected to have effects such as preventing mineral imbalance caused by high-protein diets.

Claims (1)

【特許請求の範囲】 1)ミネラル及びミネラル吸収促進材としてポリ−α又
はγ−グルタミン酸を含有することを特徴とする飲食物 2)ミネラルとしてカルシウム、鉄、マグネシウム、亜
鉛、銅などの生体必須ミネラルの一部あるいは全部を含
有することを特徴とする特許請求項第1項記載の飲食物
[Scope of Claims] 1) Foods and beverages characterized by containing poly-α or γ-glutamic acid as minerals and mineral absorption promoters 2) Minerals that are essential to living organisms such as calcium, iron, magnesium, zinc, and copper The food and drink according to claim 1, characterized in that it contains part or all of
JP1166404A 1989-06-28 1989-06-28 Foods and drinks containing easily absorbable minerals Expired - Lifetime JP2712583B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP1166404A JP2712583B2 (en) 1989-06-28 1989-06-28 Foods and drinks containing easily absorbable minerals

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1166404A JP2712583B2 (en) 1989-06-28 1989-06-28 Foods and drinks containing easily absorbable minerals

Publications (2)

Publication Number Publication Date
JPH0330648A true JPH0330648A (en) 1991-02-08
JP2712583B2 JP2712583B2 (en) 1998-02-16

Family

ID=15830793

Family Applications (1)

Application Number Title Priority Date Filing Date
JP1166404A Expired - Lifetime JP2712583B2 (en) 1989-06-28 1989-06-28 Foods and drinks containing easily absorbable minerals

Country Status (1)

Country Link
JP (1) JP2712583B2 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0605757A1 (en) * 1992-11-25 1994-07-13 Ajinomoto Co., Inc. Compositions and goods containing minerals and poly-gamma-glutamic acid
FR2704393A1 (en) * 1993-04-30 1994-11-04 Boiron Nutritional supplement which can be taken orally to optimise growth and maintain robustness of bones
JPH07127057A (en) * 1993-11-02 1995-05-16 Kajima Corp Compression system permanent anchor
EP0826310A1 (en) * 1995-05-12 1998-03-04 Ajinomoto Co., Inc. FEED COMPOSITION CONTAINING POLY-$g(g)-GLUTAMIC ACID
EP0838160A1 (en) * 1996-10-25 1998-04-29 Ajinomoto Co., Ltd. The use of poly-gamma-glutamic acid for preparing an agent for increasing the phosphorus assimilation
JP2006316022A (en) * 2005-05-16 2006-11-24 Tung Hai Biotechnology Corp gamma-POLYGLUTAMIC ACID (gamma-PGA, H FORM) AND gamma-POLYGLUTAMATE USED AS NUTRITION SUPPLEMENT IN DIETARY PRODUCT
WO2007135801A1 (en) 2006-05-23 2007-11-29 Toyo Boseki Kabushiki Kaisha MICROORGANISM CAPABLE OF PRODUCING γ-L-PGA, METHOD FOR PRODUCTION OF γ-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN
JP2011037843A (en) * 2009-07-16 2011-02-24 Kao Corp Agent for inhibiting increase in postprandial blood insulin level
JP2011037842A (en) * 2009-07-16 2011-02-24 Kao Corp Inhibitor for blood gip level elevation
US9056066B2 (en) 2011-01-12 2015-06-16 Kao Corporation Agent for suppressing elevation of blood GIP level, agent for suppressing elevation of blood insulin level, agent for lowering blood triglyceride level after meal ingestion, and agent for suppressing elevation of blood glucose level
JP2017201898A (en) * 2016-05-09 2017-11-16 ポッカサッポロフード&ビバレッジ株式会社 Beverage
JP2019534046A (en) * 2016-11-01 2019-11-28 ジロニックス・アイピー・ホールディングス・ピーティーイー.リミテッド Gamma-polyglutamic acid and zinc composition
US11944640B2 (en) 2016-11-01 2024-04-02 Xylonix PTE. LTD. Zinc-[gamma]-PGA compositions and methods for treating cancer

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6437260A (en) * 1987-08-04 1989-02-07 Takeda Chemical Industries Ltd Cereal grain food and method for improving quality thereof
JPS6437251A (en) * 1987-08-03 1989-02-07 Takeda Chemical Industries Ltd Beverage and method for improving quality thereof
JPH01132355A (en) * 1987-03-24 1989-05-24 Takeda Chem Ind Ltd Egg food and method for improving quality of said food
JPH01132331A (en) * 1987-03-24 1989-05-24 Takeda Chem Ind Ltd Polyglutamic acid-containing bakery food and shape retaining agent
JPH01132347A (en) * 1987-03-24 1989-05-24 Takeda Chem Ind Ltd Polyglutamic acid-containing noodles and shape retaining agent
JPH01165353A (en) * 1987-12-18 1989-06-29 Takeda Chem Ind Ltd Tofu product and quality improvement thereof

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01132355A (en) * 1987-03-24 1989-05-24 Takeda Chem Ind Ltd Egg food and method for improving quality of said food
JPH01132331A (en) * 1987-03-24 1989-05-24 Takeda Chem Ind Ltd Polyglutamic acid-containing bakery food and shape retaining agent
JPH01132347A (en) * 1987-03-24 1989-05-24 Takeda Chem Ind Ltd Polyglutamic acid-containing noodles and shape retaining agent
JPS6437251A (en) * 1987-08-03 1989-02-07 Takeda Chemical Industries Ltd Beverage and method for improving quality thereof
JPS6437260A (en) * 1987-08-04 1989-02-07 Takeda Chemical Industries Ltd Cereal grain food and method for improving quality thereof
JPH01165353A (en) * 1987-12-18 1989-06-29 Takeda Chem Ind Ltd Tofu product and quality improvement thereof

Cited By (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0605757A1 (en) * 1992-11-25 1994-07-13 Ajinomoto Co., Inc. Compositions and goods containing minerals and poly-gamma-glutamic acid
EP0605757B1 (en) * 1992-11-25 2001-08-16 Ajinomoto Co., Inc. Compositions and goods containing minerals and poly-gamma-glutamic acid
FR2704393A1 (en) * 1993-04-30 1994-11-04 Boiron Nutritional supplement which can be taken orally to optimise growth and maintain robustness of bones
JPH07127057A (en) * 1993-11-02 1995-05-16 Kajima Corp Compression system permanent anchor
EP0826310A1 (en) * 1995-05-12 1998-03-04 Ajinomoto Co., Inc. FEED COMPOSITION CONTAINING POLY-$g(g)-GLUTAMIC ACID
EP0838160A1 (en) * 1996-10-25 1998-04-29 Ajinomoto Co., Ltd. The use of poly-gamma-glutamic acid for preparing an agent for increasing the phosphorus assimilation
JP2006316022A (en) * 2005-05-16 2006-11-24 Tung Hai Biotechnology Corp gamma-POLYGLUTAMIC ACID (gamma-PGA, H FORM) AND gamma-POLYGLUTAMATE USED AS NUTRITION SUPPLEMENT IN DIETARY PRODUCT
WO2007135801A1 (en) 2006-05-23 2007-11-29 Toyo Boseki Kabushiki Kaisha MICROORGANISM CAPABLE OF PRODUCING γ-L-PGA, METHOD FOR PRODUCTION OF γ-L-PGA USING THE MICROORGANISM, CROSSLINKED PRODUCT, AND AGENT FOR EXTERNAL APPLICATION TO THE SKIN
JP2011037843A (en) * 2009-07-16 2011-02-24 Kao Corp Agent for inhibiting increase in postprandial blood insulin level
JP2011037842A (en) * 2009-07-16 2011-02-24 Kao Corp Inhibitor for blood gip level elevation
US8853153B2 (en) 2009-07-16 2014-10-07 Kao Corporation Agent for suppressing elevation of blood GIP concentration
US8933025B2 (en) 2009-07-16 2015-01-13 Kao Corporation Agent for suppressing postprandial elevation of blood insulin concentration
US9056066B2 (en) 2011-01-12 2015-06-16 Kao Corporation Agent for suppressing elevation of blood GIP level, agent for suppressing elevation of blood insulin level, agent for lowering blood triglyceride level after meal ingestion, and agent for suppressing elevation of blood glucose level
JP2017201898A (en) * 2016-05-09 2017-11-16 ポッカサッポロフード&ビバレッジ株式会社 Beverage
JP2019534046A (en) * 2016-11-01 2019-11-28 ジロニックス・アイピー・ホールディングス・ピーティーイー.リミテッド Gamma-polyglutamic acid and zinc composition
US11944640B2 (en) 2016-11-01 2024-04-02 Xylonix PTE. LTD. Zinc-[gamma]-PGA compositions and methods for treating cancer

Also Published As

Publication number Publication date
JP2712583B2 (en) 1998-02-16

Similar Documents

Publication Publication Date Title
RU2289955C2 (en) Nutritional formula for prophylaxis and treatment of immune conditions
KR20040105737A (en) Compositions and methods for treatment of body weight conditions with milk minerals and casein fractions
JPH0330648A (en) Readily absorbable mineral-containing food and drink
JPH07242539A (en) Composition having laxative effect
JPH07252156A (en) Medicine for prevention and therapy of osteoporosis
JP3693359B2 (en) Bone strengthening promoter
JP2002523025A (en) Composition
JP3232718B2 (en) Easy-absorbable mineral-containing composition and food and drink containing it
CN108025032A (en) Muscle synthesis accelerant
JPH0648955A (en) Activator for digestive tract cell
JPH07222571A (en) Food/beverage for athlete
JPH0621077B2 (en) Hematopoietic agent
CN1315413C (en) Compositions for appetite control and related methods
JP3552075B2 (en) Easily absorbable calcium composition
JP2009526748A (en) Calcium absorption promoter
CN108902324A (en) A kind of person in middle and old age&#39;s high-calcium milk powder and preparation method thereof
JP3551149B2 (en) Easy-absorbable mineral-containing composition and food and drink containing it
JP2016506753A (en) Food composition and use thereof
JPH08259461A (en) Lipometabolism improver
JP2900070B2 (en) Potassium supplement composition for food and method for producing the same
AU2002325007A1 (en) Compositions for appetite control and related methods
JPH0995448A (en) Increase in biotin concentration in blood and biotin-containing beverage or food product
JP2964290B2 (en) Mineral absorption enhancer
JPH11504201A (en) Dairy products fortified with crushed eggshell
JP4852681B2 (en) Intestinal cytolytic activity inhibitor

Legal Events

Date Code Title Description
EXPY Cancellation because of completion of term
FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20091031

Year of fee payment: 12